SIRT3 and neoplasm: While SIRT2 maintains its tumor suppressive properties (at least in a p53 null background), SIRT3 switches to an oncogenic role in mice fed a HFD suggesting that SIRT3 inhibition renders mice resistant to HFD-induced tumorigenesis.